MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$9,263,687
Net Income
-$1,879,677
Net Profit Margin
-20.29%
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
9,263,687
8,088,765
8,064,777.5*
9,417,179
Cost of sales
6,837,005
5,907,775
5,553,709.5*
6,343,639
Gross profit
2,426,682
2,180,990
2,511,068*
3,073,540
Accounting
164,801
175,809
381,547*
135,413
Consulting
318,864
143,148
228,097*
159,003
Taxes
-
-
-
119,909
Director fees
100,000
100,000
100,000*
100,000
Intangible assets impairment
-
-
-676,441.5*
554,650
Legal
331,003
89,076
-1,864*
193,009
Marketing
209,337
250,223
488,616.5*
235,217
Office
762,187
871,608
1,732,309.25*
614,661
R&d
13,222
31,724
131,013*
119,298
Salaries
1,923,660
1,708,484
1,442,574*
1,833,172
Taxes
138,492
129,656
117,326.25*
-
Impairment of intangible assets
0
-
-
-
Depreciation
-
-
-
95,821
Depreciation & amortization
-
76,859
83,017.5*
-
Depreciation and amortization
77,974
-
-
-
Total general & administrative expenses
4,039,540
3,576,587
4,026,195*
4,160,153
Interest income
-
48,426
43,425.5*
75,352
(loss) from operations
-1,612,858
-1,395,597
-1,515,127*
-1,086,613
Interest expense
-
-
0*
0
Loss (gain) on asset sale
-
-
20,493*
-10,250
Foreign exchange loss (gain)
-6
-18
-647.5*
253
Interest income
48,816
-
-
-
Other income
-
103,320
-
-
Settlement proceeds
0
-
-
-
Total other income
48,810
151,728
63,271*
65,355
Net (loss) before income taxes
-1,564,048
-1,243,869
-1,451,856*
-1,021,258
Provision for income taxes
0
0
541,515*
-137,438
Net (loss)
-1,564,048
-1,243,869
-1,993,371*
-883,820
Gain (loss) from foreign exchange translation
-315,629
-277,997
40,256.5*
-601,628
Comprehensive (loss)
-1,879,677
-1,521,866
-1,953,114.5
-1,485,448
Basic EPS
-1.15
-0.25
-0.571
-0.19
Basic Average Shares
1,365,324
4,905,945
3,419,205
4,555,945
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive (loss)
-$1,879,677
(-173.89%↓ Y/Y)
Net (loss)
-$1,564,048
(11.68%↑ Y/Y)
Gain (loss) from
foreign exchange...
-$315,629
(-129.10%↓ Y/Y)
Interest income
$48,816
(-32.87%↓ Y/Y)
Net (loss) before
income taxes
-$1,564,048
(21.01%↑ Y/Y)
Total other income
$48,810
(-34.62%↓ Y/Y)
Revenue
$9,263,687
(-1.56%↓ Y/Y)
Foreign exchange loss
(gain)
-$6
(-100.31%↓ Y/Y)
(loss) from operations
-$1,612,858
(21.50%↑ Y/Y)
Gross profit
$2,426,682
(-29.10%↓ Y/Y)
Cost of sales
$6,837,005
(14.19%↑ Y/Y)
Total general &
administrative expenses
$4,039,540
(-26.25%↓ Y/Y)
Salaries
$1,923,660
(-6.10%↓ Y/Y)
Office
$762,187
(-5.51%↓ Y/Y)
Legal
$331,003
(409.27%↑ Y/Y)
Consulting
$318,864
(-56.72%↓ Y/Y)
Marketing
$209,337
(3.81%↑ Y/Y)
Accounting
$164,801
(117.96%↑ Y/Y)
Taxes
$138,492
(22.91%↑ Y/Y)
Director fees
$100,000
(0.00%↑ Y/Y)
Depreciation and
amortization
$77,974
R&d
$13,222
(-93.26%↓ Y/Y)
Buy us a coffee
Sunshine Biopharma Inc. (SBFMW)
Sunshine Biopharma Inc. (SBFMW)